New cocktail targets tough pancreatic cancer
NCT ID NCT01204372
First seen Mar 16, 2026 · Last updated Apr 30, 2026 · Updated 9 times
Summary
This study tested a combination of three drugs (gemcitabine, trastuzumab, and erlotinib) as a first treatment for people with metastatic pancreatic cancer that had spread. The goal was to see if the combo could control the disease and shrink tumors. 63 patients took part, and researchers measured how well the tumors responded and how long patients lived.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Val d'Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.